MULTIPLE DERMATOFIBROMAS IN PATIENTS WITH AUTOIMMUNE DISORDERS RECEIVING IMMUNOSUPPRESSIVE THERAPY

被引:33
|
作者
COHEN, PR [1 ]
机构
[1] COLUMBIA UNIV COLL PHYS & SURG,DEPT DERMATOL,NEW YORK,NY 10032
关键词
D O I
10.1111/j.1365-4362.1991.tb04635.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Multiple dermatofibromas have been previously reported in ten patients with autoimmune disorders; in six of these, the lesions initially appeared several months after commencing treatment with immunosuppressive medications. Two additional patients with autoimmune disorders receiving systemic corticosteroid therapy who subsequently developed multiple dermatofibromas are described: a 69-year-old man with a 24-year history of pemphigus vulgaris (23 lesions on his legs) and a 22-year-old woman with a 2-year history of systemic lupus erythematosus (four lesions on her legs and trunk). The association of multiple dermatofibromas in individuals with an altered immune system may provide insight into the pathogenesis of this cutaneous condition.
引用
收藏
页码:266 / 270
页数:5
相关论文
共 50 条
  • [21] IMMUNOSUPPRESSIVE THERAPY OF AUTOIMMUNE-DISEASES
    BACH, JF
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (05) : 213 - 216
  • [22] Immunosuppressive therapy for autoimmune bullous diseases
    Meurer, Michael
    CLINICS IN DERMATOLOGY, 2012, 30 (01) : 78 - 83
  • [23] Immunosuppressive Therapy for Autoimmune Lung Diseases
    Meyer, Keith C.
    Bierach, Jennifer
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2012, 32 (04) : 633 - +
  • [24] Possibilities of immunosuppressive therapy for autoimmune diseases
    Matl, I
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 1996, 59 (03): : 167 - 167
  • [25] Infection and Infection Prevention in Patients Treated with Immunosuppressive Medications for Autoimmune Bullous Disorders
    Lehman, Julia S.
    Murrell, Dedee F.
    Camilleri, Michael J.
    DERMATOLOGIC CLINICS, 2011, 29 (04) : 591 - +
  • [26] Cytomegalovirus infection in patients with connective tissue diseases receiving immunosuppressive therapy
    Nishino, Jo
    Nagasawa, Eiji
    Tamakuma, Keiko
    Iwasaku, Yumi
    Iwadate, Tomofumi
    Onoda, Satoru
    Tosaka, Nobuko
    Mizuno, Nobuhiro
    Asano, Junichiro
    Kato, Kenichi
    Mizutani, Akiei
    Fukaya, Shusaku
    Yosida, Shunji
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S479 - S480
  • [27] Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menace
    Lin, Chih-Lin
    Kao, Jia-Horng
    HEPATOLOGY INTERNATIONAL, 2017, 11 (01) : 31 - 33
  • [28] VENO-OCCLUSIVE DISEASE OF THE LIVER IN PATIENTS RECEIVING IMMUNOSUPPRESSIVE THERAPY
    WEITZ, H
    GOKEL, JM
    LOESCHKE, K
    POSSINGER, K
    EDER, M
    VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1982, 395 (03) : 245 - 256
  • [29] Immune status and risk for infection in patients receiving chronic immunosuppressive therapy
    Glück, T
    Kiefmann, B
    Grohmann, M
    Falk, W
    Straub, RH
    Schölmerich, J
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (08) : 1473 - 1480
  • [30] PARANEOPLASTIC AUTOIMMUNE PHENOMENA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - RESPONSE TO IMMUNOSUPPRESSIVE THERAPY
    ENRIGHT, H
    JACOB, HS
    VERCELLOTTI, G
    HOWE, R
    BELZER, M
    MILLER, W
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (02) : 403 - 408